Cargando…

EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas

EZH2, as a histone methyltransferase, has been associated with cancer development and metastasis possibly through the regulation of microRNAs and cellular pathways such as EMT. In this study, the effect of EZH2 expression on miR-200c and important genes of the EMT pathway was investigated in esophag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nourmohammadi, Fatemeh, Forghanifard, Mohammad Mahdi, Abbaszadegan, Mohammad Reza, Zarrinpour, Vajiheh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622866/ https://www.ncbi.nlm.nih.gov/pubmed/36316365 http://dx.doi.org/10.1038/s41598-022-23253-2

Ejemplares similares

OMCD: OncomiR Cancer Database
por: Sarver, Aaron L., et al.
Publicado: (2018)

OncomiRs: the discovery and progress of microRNAs in cancers
por: Cho, William CS
Publicado: (2007)

Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30
por: Izadpanah, Mohammad Hossein, et al.
Publicado: (2017)

OncomiR-17-5p: alarm signal in cancer?
por: Bobbili, Madhusudhan Reddy, et al.
Publicado: (2017)

Down-regulation of traditional oncomiRs in plasma of breast cancer patients
por: Jurkovicova, Dana, et al.
Publicado: (2017)

A structural map of oncomiR-1 at single-nucleotide resolution
por: Chakraborty, Saikat, et al.
Publicado: (2017)

A simple and efficient method for cytoplasmic production of human enterokinase light chain in E. coli
por: Ebrahimifard, Mohammad, et al.
Publicado: (2022)

WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma
por: Abbaszadegan, Mohammad Reza, et al.
Publicado: (2018)

Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer
por: Gilles, Maud-Emmanuelle, et al.
Publicado: (2019)

Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy
por: Wang, Yazhe, et al.
Publicado: (2023)

INPP5A/HLA-G1/IL-10/MMP-21 Axis in Progression of Esophageal Squamous Cell Carcinoma
por: Ardalan Khales, Sima, et al.
Publicado: (2022)

Contribution of TWIST1-EVX1 Axis in Invasiveness of Esophageal Squamous Cell Carcinoma; a Functional Study
por: Ardalan Khales, Sepideh, et al.
Publicado: (2022)

miR-3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression
por: Yang, Xiu-Hua, et al.
Publicado: (2018)

MEIS1 knockdown may promote differentiation of esophageal squamous carcinoma cell line KYSE‐30
por: Mahmoudian, Reihaneh Alsadat, et al.
Publicado: (2019)

miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma
por: Liang, Hongwei, et al.
Publicado: (2016)

OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers
por: Monroig-Bosque, Paloma del C., et al.
Publicado: (2018)

miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer
por: Li, Yan, et al.
Publicado: (2019)

Mastermind-like 1 (MAML-1) as a new metastatic marker in esophageal squamous cell carcinoma
por: Forghanifard, Mohammad M, et al.
Publicado: (2010)

Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?
por: Jeang, Kuan-Teh
Publicado: (2010)

MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
por: Banno, Kouji, et al.
Publicado: (2014)

miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4
por: Liu, Yanqing, et al.
Publicado: (2016)

OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications
por: Otmani, Khalid, et al.
Publicado: (2022)

OncomiR Addiction Is Generated by a miR-155 Feedback Loop in Theileria-Transformed Leukocytes
por: Marsolier, Justine, et al.
Publicado: (2013)

Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis
por: Das, Ani V., et al.
Publicado: (2015)

MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression
por: de Melo Maia, Beatriz, et al.
Publicado: (2016)

Prognostic and Therapeutic Potentials of OncomiRs Modulating mTOR Pathways in Virus-Associated Hepatocellular Carcinoma
por: Nadda, Neeti, et al.
Publicado: (2021)

Author Correction: miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma
por: Liang, Hongwei, et al.
Publicado: (2021)

Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma
por: Moghaddam, Sara Tahbazzadeh, et al.
Publicado: (2023)

Loss of heterozygosity and microsatellite instability as predictive markers among Iranian esophageal cancer patients
por: Forghanifard, Mohammad Mahdi, et al.
Publicado: (2016)

BRCA1 as a tumor suppressor linked to the regulation of epigenetic states: keeping oncomiRs under control
por: Stefansson, Olafur Andri, et al.
Publicado: (2012)

C/EBPβ mediates RNA polymerase III-driven transcription of oncomiR-138 in malignant gliomas
por: Di Pascale, Federica, et al.
Publicado: (2018)

Effect of Combined Perftoran and Indocyanine Green-Photodynamic Therapy on HypoxamiRs and OncomiRs in Lung Cancer Cells
por: Gamal-Eldeen, Amira M., et al.
Publicado: (2022)

Environmental and Lifestyle Cancer Risk Factors: Shaping Extracellular Vesicle OncomiRs and Paving the Path to Cancer Development
por: Bollati, Valentina, et al.
Publicado: (2023)

MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma
por: Zargari, Selma, et al.
Publicado: (2020)

Molecular Signaling in Tumorigenesis of Gastric Cancer
por: Molaei, Fatemeh, et al.
Publicado: (2018)

Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer
por: Dhar, Swati, et al.
Publicado: (2015)

Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma
por: Janiszewska, Joanna, et al.
Publicado: (2015)

The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients
por: Mavridis, K, et al.
Publicado: (2015)

miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis
por: Seashols-Williams, S. J., et al.
Publicado: (2016)

Role of MAML1 in targeted therapy against the esophageal cancer stem cells
por: Moghbeli, Meysam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4j597h0i2fbvoc74q37r34eiae